Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers
- 1 August 2014
- journal article
- review article
- Published by Elsevier BV in Oral Oncology
- Vol. 50 (8), 683-690
- https://doi.org/10.1016/j.oraloncology.2014.04.008
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Whole exome sequencing of adenoid cystic carcinomaJCI Insight, 2013
- The mutational landscape of adenoid cystic carcinomaNature Genetics, 2013
- New tricks from an old oncogeneCell Cycle, 2010
- CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behaviorGenes, Chromosomes and Cancer, 2007
- Systemic Therapy in the Palliative Management of Advanced Salivary Gland CancersJournal of Clinical Oncology, 2006
- Fusion oncogenes and tumor type specificity—insights from salivary gland tumorsSeminars in Cancer Biology, 2005
- Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumorsExperimental Cell Research, 2004
- TORCs: Transducers of Regulated CREB ActivityMolecular Cell, 2003
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003
- Recurrent rearrangements of 11q14–22 in mucoepidermoid carcinomaCancer Genetics and Cytogenetics, 1994